E. Randy Craven - Concepedia

Author

E. Randy Craven

Also Known As

Charles J. Crane, Craven, Craven,E Randy, DonaldU Stone, E Craven, E Randy Craven, E. Randy Craven, E.Randy Craven, ERandy Craven, Earl R. Craven

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Allergan (United States)Johns Hopkins University King Khaled Eye Specialist Hospital Johns Hopkins Medicine AbbVie (United States)

About

E. Randy Craven is an author at Allergan (United States) specializing in medicine, ophthalmology, and glaucoma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	618
2	Anesthesia	2	2	34
3	Engineering	1	1	41
4	Biomedical Engineering	1	1	41
5	Plastic Surgery	1	1	41

E. Randy Craven

Publications

Citations

H-Index

Page 1

	Year	Citations
Identification of a Gene That Causes Primary Open Angle Glaucoma Edwin M. Stone, John H. Fingert, Wallace L.M. Alward, Science	1997	1.4K
Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: Two-year follow-up E. Randy Craven, Jay Katz, Jeffrey M. Wells, Journal of Cataract & Refractive Surgery	2012	337
Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts Steven D. Vold, Iqbal Ike K. Ahmed, E. Randy Craven, Ophthalmology Open-angle GlaucomaOphthalmic SurgeryVitreous BodyOphthalmologySurgery	2016	267
A Schlemm Canal Microstent for Intraocular Pressure Reduction in Primary Open-Angle Glaucoma and Cataract Thomas W. Samuelson, David F. Chang, Robert E. Marquis, Ophthalmology OphthalmologySchlemm Canal MicrostentExperimental OphthalmologySurgeryIntraocular Pressure Reduction	2018	215
Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial Richard A. Lewis, William C. Christie, Douglas G. Day, American Journal of Ophthalmology	2016	123
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients E. Randy Craven, Thomas R. Walters, William C. Christie, Drugs	2019	97
A Three-Month, Multicenter, Double-Masked Study of the Safety and Efficacy of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Compared to Travoprost 0.004% Ophthalmic Solution and Timolol 0.5% Dosed Concomitantly in Subjects With Open Angle Glaucoma or Ocular Hypertension Bret A. Hughes, Jason Bacharach, E. Randy Craven, Journal of Glaucoma	2005	92
Brimonidine and Timolol Fixed-Combination Therapy Versus Monotherapy: A 3-Month Randomized Trial in Patients with Glaucoma or Ocular Hypertension E. Randy Craven, Thomas R. Walters, Robert D. Williams, Journal of Ocular Pharmacology and Therapeutics	2005	79
Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost Katz, Clark Springs, E. Randy Craven, Clinical ophthalmology	2010	59
Applanation Tonometer Tip Sterilization for Adenovirus Type 8 E. Randy Craven, Sandra L. Butler, James P. McCulley, Ophthalmology Diagnostic VirologyAdenovirus Type 8VirologyInfection ControlMedicine	1987	45

Page 1